Elevance Health (ELV): Price and Financial Metrics

Elevance Health (ELV): $489.08

-3.45 (-0.70%)

POWR Rating

Component Grades













ELV Stock Price Chart Interactive Chart >

Price chart for ELV

ELV Price/Volume Stats

Current price $489.08 52-week high $549.52
Prev. close $492.53 52-week low $431.96
Day low $488.62 Volume 818,100
Day high $496.68 Avg. volume 1,263,900
50-day MA $501.31 Dividend yield 1.05%
200-day MA $492.02 Market Cap 117.38B

Elevance Health (ELV) Company Bio

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

ELV Latest News Stream

Event/Time News Detail
Loading, please wait...

ELV Latest Social Stream

Loading social stream, please wait...

View Full ELV Social Stream

Latest ELV News From Around the Web

Below are the latest news stories about ELEVANCE HEALTH INC that investors may wish to consider to help them evaluate ELV as an investment opportunity.

Elevance Health (ELV) Q4 2022 Earnings Call Transcript

Image source: The Motley Fool. Elevance Health (NYSE: ELV)Q4 2022 Earnings CallJan 25, 2023, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth quarter earnings conference call.

Yahoo | January 25, 2023

Elevance Health's 2.750% Senior Convertible Debentures due 2042 to Accrue Contingent Interest

INDIANAPOLIS, January 25, 2023--Elevance Health, Inc. (NYSE: ELV) announced today that for the six-month interest period commencing on October 15, 2022, its 2.750% Senior Convertible Debentures due 2042 (the "Debentures") will accrue contingent interest at a rate of 0.50% per annum of the average trading price of a Debenture for the ten consecutive trading days ended October 14, 2022. Contingent interest, which the Company has determined to be approximately $16.8123 per Note, will be payable on

Yahoo | January 25, 2023

Elevance Health (ELV) Tops on Q4 Earnings, Hikes Dividend

Elevance Health's (ELV) fourth-quarter earnings gain on solid premiums from its Medicaid business. Management approves a quarterly dividend hike of 16%.

Yahoo | January 25, 2023

Elevance Health Revenue Lifted by Higher Premiums

Elevance Health reported higher revenue but a smaller profit for the fourth quarter as premiums rose in tandem with medical costs. The health insurer and healthcare-services provider, formerly known as Anthem Inc., said Wednesday that total revenue increased 9.2% to $39.93 billion, topping analyst expectations of $39.77 billion, according to FactSet. Total premiums were up 9.4% thanks to higher rates and more Medicaid and Medicare Advantage plan members.

Yahoo | January 25, 2023

Elevance Health (ELV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Elevance Health (ELV) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Yahoo | January 25, 2023

Read More 'ELV' Stories Here

ELV Price Returns

1-mo -4.66%
3-mo -8.89%
6-mo 3.51%
1-year 12.07%
3-year 91.11%
5-year 112.75%
YTD -4.66%
2022 11.83%
2021 46.12%
2020 7.74%
2019 16.33%
2018 18.11%

ELV Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ELV Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6589 seconds.